Dupain, Célia
Gutman, Tom
Girard, Elodie
Kamoun, Choumouss
Marret, Grégoire
Castel-Ajgal, Zahra
Sablin, Marie-Paule
Neuzillet, Cindy
Borcoman, Edith
Hescot, Ségolène
Callens, Céline
Trabelsi-Grati, Olfa
Melaabi, Samia
Vibert, Roseline
Antonio, Samantha
Franck, Coralie
Galut, Michèle
Guillou, Isabelle
Halladjian, Maral
Allory, Yves
Cyrta, Joanna
Romejon, Julien
Frouin, Eleonore
Stoppa-Lyonnet, Dominique
Wong, Jennifer
Le Tourneau, Christophe
Bièche, Ivan
Servant, Nicolas
Kamal, Maud
Masliah-Planchon, Julien
Funding for this research was provided by:
Institut Curie
Amgen France
La Ligue Contre le Cancer
Cancéropole Ile-de-France
Article History
Received: 29 November 2022
Accepted: 2 February 2024
First Online: 20 February 2024
Declarations
:
: The study was approved by Institut Curie’s internal committee. Informed consent with regard to the collection of tumor samples and molecular analysis was obtained from patients within the IC institutional general consent signed by every patient treated at the IC.
: Not applicable.
: EB received honoraria and nonfinancial support from Eisai, MSD, Sandoz, Daiichi Sankyo.All other authors declare that they have no competing interests.